Meeting
2016 Gastrointestinal Cancers Symposium
The lymphocyte-to-monocyte ratio as a predictor of overall survival in comparison to established systemic markers of inflammation in resectable colorectal cancer.
Authors
Joseph Chan
Kolling Institute of Medical Research, University of Sydney, St. Leonards, Australia
Joseph Chan , Connie Irene Diakos , David Chan , Anthony J Gill , Alexander Engel , Stephen John Clarke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 593)
DOI
10.1200/jco.2016.34.4_suppl.593
Abstract #
593
Poster Bd #
E20
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Change in inflammatory status as a prognostic marker of overall survival in colorectal patients undergoing resection.
First Author: Joseph Chan
Poster
2022 ASCO Annual Meeting
Prognostic role of systemic inflammatory markers in patients with metastatic MSI-h/dMMR colorectal cancer receiving immunotherapy.
First Author: Deepak Bhamidipati
Poster
2020 Gastrointestinal Cancers Symposium
The pretreatment lymphocyte-to-monocyte ratio (LMR) to predict treatment efficacy and prognosis in metastatic colorectal cancer treated with the combination of TAS-102 and bevacizumab (TAS-CC3 Study).
First Author: Akihisa Matsuda
Poster
2019 Genitourinary Cancers Symposium
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for overall survival in men with advanced prostate cancer treated with platinum chemotherapy.
First Author: Panagiotis J. Vlachostergios